SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-031519
Filing Date
2015-02-03
Accepted
2015-02-03 16:16:35
Documents
5
Period of Report
2015-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d864170d8k.htm 8-K 26104
2 EX-10.1 d864170dex101.htm EX-10.1 26305
3 EX-99.1 d864170dex991.htm EX-99.1 123496
4 EX-99.2 d864170dex992.htm EX-99.2 12544
5 GRAPHIC g864170g53u96.jpg GRAPHIC 2878
  Complete submission text file 0001193125-15-031519.txt   193858
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 15571318
SIC: 2835 In Vitro & In Vivo Diagnostic Substances